Latest Schedule 13D activist filings

LSP 7 Cooperatieve U.A. and LSP 7 Management B.V. have disclosed a 10.6% beneficial ownership in AgomAb Therapeutics NV following an IPO and additional share purchases.

Transocean Ltd. announces a definitive agreement to acquire Valaris Limited, combining two leading offshore drilling contractors through a scheme of arrangement.

Transocean Ltd. announces a definitive agreement to acquire Valaris Limited, combining two leading offshore drilling contractors through a scheme of arrangement.

K2 Capital Sponsor LLC and its managing member, Karan Thakur, have filed a Schedule 13D disclosing beneficial ownership of 30.17% of K2 Capital Acquisition Corp's ordinary shares.

XP Control LLC and Guilherme Dias Fernandes Benchimol reported a realignment of interests within XP Control LLC, leading to a slight decrease in their beneficial ownership of XP Inc. Class A common shares.

Anthony Hsieh's beneficial ownership of loanDepot Class A Common Stock reached 31.83% following the automatic conversion of Class C shares to Class B.

FreeCast CEO William A. Mobley, Jr. and Nextelligence, Inc. report a combined beneficial ownership of 93.1% of FreeCast's Class A Common Stock, signaling control.

New Enterprise Associates funds and their managers have filed a Schedule 13D, revealing a significant 22.2% beneficial ownership in SpyGlass Pharma, Inc. following its recent IPO.

Michael N. Taglich has increased his beneficial ownership in Air Industries Group to 14.3% through various transactions including share acquisitions and option exercises.

Robert Taglich has increased his beneficial ownership in Air Industries Group to 10.1% through a series of transactions including purchases and option receipts.

Dagmar Dolby and related trusts decreased their beneficial ownership in Dolby Laboratories, Inc. by over one percent primarily due to charitable gifting.

Pfizer Inc. reported a decrease in its beneficial ownership of Allogene Therapeutics, Inc. common stock to 9.0%, solely due to an increase in Allogene's outstanding shares.

Pfizer Inc. reported a decrease in its beneficial ownership of Allogene Therapeutics, Inc. common stock to 9.0%, solely due to an increase in Allogene's outstanding shares.

Bryant R. Riley, a significant shareholder in BRC Group Holdings, Inc., reduced his pledged shares by 53.7% after repaying over $10 million of a loan from Axos Bank.

Horton Capital Partners and Joseph M. Manko, Jr. filed an amended Schedule 13D detailing changes in their beneficial ownership of KORU Medical Systems, Inc. common stock, including share distributions and director compensation.

FalconX Holdings Limited and its affiliates have increased their beneficial ownership in Sharps Technology, Inc. to 16.5%, signaling active engagement in strategic direction.

Juniper Investment Company and its affiliates have increased their beneficial ownership in Orthofix Medical Inc. to 9.6% through recent open market purchases.

James H. Dahl and Rainey E. Lancaster have increased their beneficial ownership in AMREP Corporation, with Dahl now holding 17.8% of outstanding shares.

Cambridge Sponsor LLC and Michael Cam-Phung report a combined beneficial ownership of 26.19% in Cambridge Acquisition Corp. following the company's initial public offering.

FalconX Holdings Limited and its affiliates have significantly increased their beneficial ownership in Sharps Technology, Inc. to 20.0% through a $45.7 million private placement of common stock and warrants.

Eric Li, through various entities including ECARX Holdings, increased his beneficial ownership in Lotus Technology Inc. to 56.0% following a $23 million private placement.

New Enterprise Associates (NEA) has filed an amendment to correct beneficial ownership disclosures for Trevi Therapeutics, Inc., reflecting prior warrant exercises.

Andrew F. Knaggs and The NYX 2025 Irrevocable Trust UA report a 10.03% beneficial ownership in Evolution Metals & Technologies Corp. following a business combination.

Edward W. Cochran has increased his beneficial ownership in CF Bankshares Inc. to 5.5% of outstanding common stock, acquired through personal funds for private investment.

Saba Capital Management and affiliates increased their beneficial ownership in ASA Gold and Precious Metals Limited to 31.01% through recent open market purchases.

The DD Revocable Trust has become the beneficial owner of 9.11% of Xerox Holdings Corp's common stock following the passing of Darwin Deason.

Following the passing of Darwin Deason, his significant stake in Conduent Incorporated, representing 7.59% of common stock, has been transferred to the DD Revocable Trust.

Tyson Limited Partnership filed an Amendment No. 13 to its Schedule 13D, updating the trustees for the Tyson Family GP Trust and the Donald J. Tyson Revocable Trust, which are general partners controlling Tyson Foods, Inc.

McCormick & Company's Chairman, President, and CEO, Brendan M. Foley, reported beneficial ownership of 5.1% of the company's Common Stock, primarily through equity compensation.

Curtis A. Loveland, as trustee for the Funk trusts, reported significant sales of SCI Engineered Materials, Inc. common stock, reducing beneficial ownership to 3.5%.